Notalgia Paresthetica
Conditions
Keywords
back pain, intralesional injection, neuralgia, pruritus
Brief summary
Patients diagnosed with Notalgia paresthetica and who received neural therapy within the last year were retrospectively screened. In the evaluations before treatment and at the 3rd month after treatment; Numerical rating scale for pain, PainDETECT questionnaire for neuropathic pain, SF-12 for quality of life and 5-D itch scale for itch level were used.
Interventions
OTHERNeural Therapy
The injection was prepared using a solution of lidocaine 2% and saline 0.9%. A 0.4% lidocaine solution was prepared by diluting 1 cc of lidocaine with 4 cc of saline.
Sponsors
Sisli Hamidiye Etfal Training and Research Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* the presence of a hyperpigmented skin lesion consistent with NP * minimum 6 months for duration of disease * 30-60 aged * application of neural therapy in a manner appropriate to the diagnosis
Exclusion criteria
* history of previous surgery or injection in the thoracic region * presence of another treatment in the same period * presence of any cardiac or pulmonary disease, malignancy, or advanced psychiatric disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Numeric Rating Scale for Pain | 12 weeks after treatment | A scale between 0 and 10 was used to question the pain level. |
| PainDETECT Questionnaire for assessing Neuropathic pain | 12 weeks after treatment | The questionnaire consists of 9 items and is completed by the patient (no clinical examination is required)\[1\]\[3\]. There are 7 weighted sensory descriptor items (never to very strongly) and 2 items relating to spatial and temporal pain characteristics\[3\]. A total score of 19 or more is indicative of likely neuropathic pain. |
| Short Form-12 for Quality of life | 12 weeks after treatment | The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure. |
| 5-D Itch Scale | 12 weeks after treatment | The 5-D itch scale is a 5-domain disease-specific instrument evaluating the duration, degree (severity), direction (improving, unaltered or worsening), disability (impact on sleep, leisure/social, housework/errands and school/work activities) and distribution (body part affected) |
Countries
Turkey (Türkiye)
Outcome results
None listed